Cold autoimmune hemolytic anemia

Cold autoimmune hemolytic anemia
Synonyms	Cold agglutinin disease
Pronounce	N/A
Specialty	N/A
Symptoms	Fatigue, pallor, jaundice, dark urine, cold-induced acrocyanosis
Complications	Anemia, Raynaud's phenomenon, hemolytic crisis
Onset	Typically in adulthood
Duration	Chronic
Types	N/A
Causes	Autoimmune disease, often idiopathic or secondary to infections or other conditions
Risks	Infections, lymphoproliferative disorders
Diagnosis	Direct Coombs test, blood smear, cold agglutinin titer
Differential diagnosis	Warm autoimmune hemolytic anemia, paroxysmal cold hemoglobinuria, cryoglobulinemia
Prevention	N/A
Treatment	Avoidance of cold, rituximab, corticosteroids, plasmapheresis
Medication	N/A
Prognosis	Variable, depends on underlying cause and response to treatment
Frequency	Rare
Deaths	N/A

Cold Autoimmune Hemolytic Anemia

Cold Autoimmune Hemolytic Anemia (CAHA) is a rare type of autoimmune hemolytic anemia (AIHA) characterized by the premature destruction of red blood cells (RBCs) at low temperatures. This condition is mediated by autoantibodies that bind to RBCs, leading to their destruction by the immune system.

Pathophysiology

In CAHA, the immune system produces cold agglutinins, which are antibodies that react with RBCs at temperatures below normal body temperature, typically between 0°C and 30°C. These antibodies are usually of the IgM class and can cause RBCs to clump together (agglutinate) and be destroyed, primarily in the liver and spleen.

Symptoms

The symptoms of CAHA can vary depending on the severity of the condition and the degree of hemolysis. Common symptoms include:

• Fatigue
• Pallor
• Jaundice
• Dark urine
• Cold-induced acrocyanosis

Diagnosis

Diagnosis of CAHA involves several laboratory tests, including:

• Complete blood count (CBC) showing anemia
• Direct Coombs test (direct antiglobulin test) positive for complement
• Detection of cold agglutinins in the blood
• Blood smear showing agglutinated RBCs

Treatment

Treatment of CAHA focuses on managing symptoms and preventing hemolysis. Strategies include:

• Avoiding exposure to cold temperatures
• Use of immunosuppressive drugs such as rituximab
• Plasmapheresis in severe cases

Prognosis

The prognosis for individuals with CAHA varies. Some patients may experience mild symptoms, while others may have severe anemia requiring medical intervention. The condition can be chronic, with periods of remission and exacerbation.

See Also

• Autoimmune hemolytic anemia
• Warm autoimmune hemolytic anemia
• Hemolytic anemia

References

• ,

 Cold agglutinin disease, 
 Hematology, 
 2016,
 Vol. 2016(Issue: 1),
 pp. 226-231,
 DOI: 10.1182/asheducation-2016.1.226,

• ,

 Hoffbrand's Essential Haematology, 
 7th edition, 
 Wiley-Blackwell, 
 2016, 
  
  
 ISBN 978-1118408674,

External Links

• Mayo Clinic - Autoimmune Hemolytic Anemia